Blog Post: Day 15 of $QQQ short term up-trend; $LLY rocketing towards GLB as obesity drug is up for approval, see daily, weekly and monthly charts


$LLY may soon receive approval for their obesity drug, which may prove to be a blockbuster drug. It appears that the stock is rising in anticipation of results from a second Phase 3 trial, expected this month. This could be big if LLY can break above its green line ATH peak at $375.25. I have a very small position and will add to it if we get a GLB (green line break-out). Thanks to my stock buddy, Judy, for telling me about LLY many months ago.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.